Non-specific ocular surface and mitochondrial components

The designation Non-specific ocular surface and mitochondrial components refers to a broad category of biological structures and organelles rather than a single, defined molecular target. This classification is typically employed in drug development databases for agents whose precise molecular mechanism of action is either not fully characterized or involves multi-factorial interactions across the ocular surface and within mitochondria. For instance, mitochondria-targeted antioxidants such as SkQ1 (Visomitin) are designed to localize to the inner mitochondrial membrane to neutralize reactive oxygen species, thereby mitigating oxidative stress in conditions like dry eye disease (Antonenko et al., 2008). On the ocular surface, various therapeutic agents may act by providing physical lubrication or stabilizing the tear film, affecting the cornea and conjunctiva without binding to a specific receptor (Gipson, 2007). Because this term encompasses a wide range of physical and chemical interactions rather than a specific protein or gene, it does not function as a canonical therapeutic target. Consequently, it is often used as a placeholder for drugs with non-specific or systemic effects on these cellular compartments (Murphy and Smith, 2007).

Other names

Mitochondrial componentsOcular surface componentsNon-specific ocular targets

Antioxidant scavenging of reactive oxygen species within mitochondrial membranes and physical stabilization of the tear film on the ocular surface.